Showing results (481-490 of 5,984) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|February 25, 2014
Aurora kinase inhibition induces PUMA via NF-κB to kill colon cancer cellsJing Sun, Kyle Knickelbein, Kan He, et al.Molecular Cancer Therapeutics|February 8, 2014
Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cellsScott A Bergfeld, Laurence Blavier, Yves A DeClerckMolecular Cancer Therapeutics|April 6, 2017
U1 Adaptors Suppress the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer XenograftsAshley T Tsang, Crissy Dudgeon, Lan Yi, et al.Molecular Cancer Therapeutics|April 6, 2017
Biological Role and Therapeutic Targeting of TGF-β3 in GlioblastomaKatharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt, et al.Molecular Cancer Therapeutics|March 4, 2017
Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398Jharna Datta, Senthilkumar Damodaran, Hannah Parks, et al.Molecular Cancer Therapeutics|April 12, 2017
Novel Indole-based Tambjamine-Analogues Induce Apoptotic Lung Cancer Cell Death through p38 Mitogen-Activated Protein Kinase ActivationPilar Manuel-Manresa, Luís Korrodi-Gregório, Elsa Hernando, et al.Molecular Cancer Therapeutics|June 6, 2008
Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growthZhenwen Yan, Huafei Zou, Fang Tian, et al.Molecular Cancer Therapeutics|April 17, 2008
Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigeneticsAnnamaria Hadnagy, Raymond Beaulieu, Danuta BalickiMolecular Cancer Therapeutics|April 17, 2008
Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacyCathy Zhang, Karen Lundgren, Zhengming Yan, et al.Molecular Cancer Therapeutics|April 17, 2008
Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosisJorge L Martínez-Torrecuadrada, Lawrence H Cheung, Paula López-Serra, et al.Pageof 599